HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Infant botulism].

Abstract
Infant botulism is a paralytic syndrome which manifests as a result of ingesting spores of the toxin secreting bacterium Clostridium botulinum by infants. As opposed to botulism in adults, treating infant botulism with horse antiserum was not approved due to several safety issues. This restriction has led to the development of Human Botulism Immune Globulin Intravenous (BIG-IV; sells under BabyBIG). In this article we review infant botulism and the advantages of treating it with BIG-IV.
AuthorsAbsalom Falk, Amichay Afriat, Yechiel Hubary, Lior Herzog, Arik Eisenkraft
JournalHarefuah (Harefuah) Vol. 153 Issue 3-4 Pg. 180-3, 238 ( 2014) ISSN: 0017-7768 [Print] Israel
PMID24791561 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Immunoglobulins
  • Immunologic Factors
  • botulism immune globulin
Topics
  • Age Factors
  • Botulism (drug therapy, microbiology, physiopathology)
  • Clostridium botulinum (isolation & purification)
  • Humans
  • Immunoglobulins (therapeutic use)
  • Immunologic Factors (therapeutic use)
  • Infant

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: